Skip to content
In deliveryUnited KingdomGoods£6,746,917

THH - Supply of Patient-Specific Cytotoxic and Advjuvant Products

Published
Published 13 November 2025
Deadline
Closed 8 December 2025

Overview

The Hillingdon Hospitals NHS Foundation Trust awarded a contract to Baxter for the supply of patient-specific cytotoxic and adjuvant products on an as-needed basis. The contract value is £9,288,098.95 and is currently in delivery or complete status.

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£6,746,917
Procedure
Open
SME suitable
Yes
Published
13 November 2025
Questions by
28 November 2025
Deadline
Closed
Classification (CPV)
Medical equipments, pharmaceuticals and personal care products

Award outcome

Awarded value
£9,288,099
Award date
27 May 2026
Contract period
3 February 2026 → 2 February 2029
Winner
  • Baxter

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    10 June 2026

    View notice ↗
  2. Contract Notice

    13 November 2025

    View notice ↗

Contracting authority

  • Central London Community Healthcare NHS Trust

    Procuring entity

    London, United Kingdom

    GB-PPON: PJXH-4297-MQQW

    Authority website ↗
  • The Hillingdon Hospitals NHS Foundation Trust

    Buyer

    Uxbridge, United Kingdom

    GB-PPON: PNPL-3913-VPHM

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: THH - Supply of Patient-Specific Cytotoxic and Advjuvant Products — won by Baxter — Skim